Skip to content
Discreet worldwide shipping LegitScript Certified Cold-chain delivery 30-day returns
Upload Rx
0 0
Mounajro 5 mg Injection Vial 39% Off
Sourced directly from Eli Lilly
Cold chain

Mounajro 5 mg Injection Vial

Injection · 1 Vial per Pack

$65.00 $107.00 incl. taxes
Composition
—
Manufacturer
Eli Lilly
Pack
1 Vial per Pack
No reviews yet Write a review
Select dosage
  • Genuine stock
  • Discreet packaging
  • Export documents on request
Out of stock

Standard 7–15 business days · Express 4–6 business days. Enter your postal code to confirm.

About Mounajro 5 mg Injection Vial

Mounjaro 5 mg Injection contains tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes and weight management. It helps improve blood sugar control, reduce appetite, and support significant weight loss. Administered once weekly under medical supervision.

What Is Mounjaro 5 mg Injection?

Mounjaro is the brand name for tirzepatide, a breakthrough medication that targets two important metabolic pathways simultaneously: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).

Most diabetes medications focus on a single pathway.

Tirzepatide works differently.

By activating both GIP and GLP-1 receptors, it helps regulate blood sugar more effectively while also reducing hunger and calorie intake. This dual mechanism is one reason Mounjaro has generated significant attention among endocrinologists and obesity specialists worldwide.


How It Works — And Why It Produces More Weight Loss Than Older GLP-1 Drugs

Many diabetes treatments lower blood sugar.

Fewer help patients lose substantial weight.

Tirzepatide stimulates insulin release when blood sugar rises, suppresses glucagon production, slows gastric emptying, and reduces appetite signals in the brain.

The result is often:

  • Improved blood sugar control
  • Lower HbA1c levels
  • Reduced appetite
  • Smaller meal portions
  • Significant weight reduction over time

Clinical studies have shown tirzepatide can produce greater weight loss than many older GLP-1 receptor agonists when used alongside diet and lifestyle modifications.


Who Is Usually Prescribed Mounjaro?

Doctors commonly prescribe Mounjaro for:

  • Type 2 diabetes mellitus
  • Patients requiring improved HbA1c control
  • Overweight or obese individuals with metabolic disease
  • Patients not achieving targets with other diabetes medications
  • Long-term weight management programs (where clinically appropriate)

Mounjaro is not intended for type 1 diabetes.


Medical Uses & Indications

Condition How Mounjaro May Help
Type 2 Diabetes Improves blood sugar control
Elevated HbA1c Helps achieve glycemic targets
Obesity Supports clinically significant weight loss
Insulin Resistance Improves metabolic regulation
Metabolic Syndrome Supports weight and glucose management

Why Many Specialists Consider Tirzepatide a Major Advance

Most medications either focus on diabetes or weight loss.

Tirzepatide addresses both.

This dual-action approach is why Mounjaro has become one of the most discussed medications in modern endocrinology. For many patients, weight reduction itself contributes to improved glucose control, creating a beneficial cycle that supports long-term metabolic health.

While not a cure for diabetes, it represents one of the most effective non-insulin treatment options currently available.


Typical Dosage Guide

Strength Common Clinical Use
2.5 mg Initial starter dose
5 mg Early maintenance dose
7.5 mg Dose escalation
10 mg Intermediate maintenance
12.5 mg Advanced titration
15 mg Maximum approved maintenance dose

Dose escalation is typically gradual to improve tolerability and reduce gastrointestinal side effects.


Product Information

Attribute Details
Generic Name Tirzepatide
Brand Name Mounjaro®
Drug Class Dual GIP/GLP-1 Receptor Agonist
Dosage Form Injection
Route of Administration Subcutaneous Injection
Used For Type 2 Diabetes, Weight Management
Dosing Frequency Once Weekly

People Also Ask

Is Mounjaro the same as Ozempic?

No. Ozempic contains semaglutide and targets GLP-1 receptors only. Mounjaro contains tirzepatide and targets both GIP and GLP-1 receptors.

How much weight can patients lose with Mounjaro?

Weight loss varies between individuals. Many patients experience meaningful reductions in body weight when combined with dietary changes and medical supervision.

Is Mounjaro approved for diabetes?

Yes. Mounjaro is approved for improving blood sugar control in adults with type 2 diabetes.

How often is Mounjaro injected?

Mounjaro is typically administered once weekly.

Can Mounjaro replace insulin?

Some patients may reduce their need for insulin, but treatment decisions should always be made by a healthcare professional.

How quickly does Mounjaro start working?

Blood sugar improvements can begin within weeks, while weight-loss effects generally become more noticeable over several months.


Frequently Asked Questions

1. Do you ship Mounjaro internationally?

Answer: Yes. International shipping is available to many countries, subject to local regulations and product availability.

2. Is this genuine Mounjaro by Eli Lilly?

Answer: Product availability may include original branded Mounjaro® manufactured by Eli Lilly, depending on stock and sourcing.

3. How is the product packaged?

Answer: Products are supplied in manufacturer-sealed pharmaceutical packaging and packed securely for export.

4. How can I verify authenticity?

Answer: Verify manufacturer details, batch number, expiry date, and original packaging upon receipt.

Also in Weight Loss

View all
View all